Ownership Summary
Clearmind Medicine Inc. (NASDAQ:CMND) is held by 5 institutional investors per 13F filings through March 2026.
- These investors held 3.9% of outstanding shares in March 2026, down from 5.2% in December 2025.
- Their total shares held in CMND increased 576.74% quarter over quarter, and separately, investors owning Clearmind Medicine decreased 37.5% from a year ago.
- During the quarter, 4 of these 5 funds increased positions in CMND, 0 reduced exposure, and 1 held steady.
- Altogether, these fund groups held 4.5K shares in CMND by March 2026, up by 3.83K shares quarter on quarter, and down 10.56K shares year over year.
- XTX Topco Ltd is the top holder of Clearmind Medicine as of March 31, 2026, with 2.17K shares representing 1.87% of outstanding stock.
- The biggest buyers of Clearmind Medicine for the quarter ending March 2026 included XTX Topco Ltd (2.17K), HRT FINANCIAL LP (1.59K), AdvisorShares Investments LLC (72), UBS Group AG (0).
- According to Business Quant data, leading holders of CMND for March 2026 are XTX Topco Ltd (2.17K), HRT FINANCIAL LP (1.59K), AdvisorShares Investments LLC (735), Royal Bank Of Canada (1), UBS Group AG (0).